Navigation Links
Cervical Cancer Vaccine Approved for Use

Medicines Safety Authority Medsafe has approved the use of Gardasil, cervical cancer vaccine on Thursday. Several health professionals are calling for its use in a national// immunization program.

The vaccine is said to offer immunity against four strains of Human Papilloma Virus (HPV) which is a common sexually transmitted infection. Although HPV infects about half of sexually active adults sometime during their life, it is usually harmless. However, it can cause the development of abnormal cells in the cervix lining, which can turn cancerous.

Presently Gardasil is recommended for use from ages 9 to 26, before women become sexually active and is expected to eventually included in the national immunization schedule.

Still Medsafe says women will need to have regular pap smears because of limited protection, besides which it is not known how long the vaccine will last.

According to Biopharmaceutical company CSI Limited Gardasil will be available in New Zealand in September.

The vaccine will have to be included in the Ministry of Health's national immunization program before its nationwide implementation. However the next review of its schedule isn't due until 2008.

Dr Dynes McConnell, from the Royal Australasian College of Obstetricians and Gynaecologists has warned for the need for action before then. She says that New Zealand will face a risk of falling behind if the vaccine is not introduced on a national level within the next one to three years.

Each year around 180 women are diagnosed with cervical cancer in New Zealand and around 60 die from the disease.


'"/>




Page: 1

Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Smallpox Vaccine May Help Fight Cervical Cancer
3. Obesity Increases Risk of Cervical Cancer
4. Reducing The Risk Of Cervical Cancer
5. Improving Fertility In Patients With Cervical Cancer
6. Vaccine for Cervical cancer
7. Cervical spinal injury patients may have more damage left undetected
8. Cervical Cancer Vaccine To Be Developed In India
9. Cervical Cancer Can Now Be Better Handled With Gene Silencing Therapy
10. Cervical Cancer Recurrence Risk Even After Removal Of Pre-Cancerous Cells
11. HPV Vaccines for Cervical Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/16/2017)... Battle Creek, MI (PRWEB) , ... January 17, 2017 , ... ... substance abuse located in Southwest Michigan, joined other volunteers and organizations in support of ... sees hundreds of children and families dressed up in colorful costumes of all designs ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... their groundbreaking GunSport•PRO® and EB15•LE® electronic earplugs at the NSSF SHOT Show on ... Booth #2809. The SHOT Show is the shooting, hunting and outdoor trade show ...
(Date:1/16/2017)... , ... January 16, 2017 , ... ... , Antoine Dental Center, is currently offering complimentary consultations and financing for orthodontics ... teeth examined for bite irregularities and learn about their orthodontic options. Walk-in, late-evening, ...
(Date:1/16/2017)... ... 2017 , ... Specialty Technical Publishers (STP) and Specialty Technical ... (IAPC) EHS audit protocol for Singapore . Leading companies around the world ... obligations and rapidly collect, share, archive, and export audit findings in a cost ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... science teacher, http://www.ageofautism.com/legal , Sharon Kleyne, America’s leading water educator, researcher ... her nationally syndicated radio program, The Sharon Kleyne Hour Power of Water, Global ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... BAUDETTE, Minn. , Jan. 17, 2017 /PRNewswire/ ... ) today announced the appointment of Karen Quinn ... January 17, 2017.  Karen ... years of leadership experience in Global Regulatory Affairs, ... biologically-derived active pharmaceutical ingredients.  Dr. Quinn worked most ...
(Date:1/17/2017)... pioneer in no-touch UV disinfection has now been validated by ... for "total room ultraviolet disinfection," was the device of choice ... study which was recently published in The Lancet ... transmission of four major superbugs by a cumulative 30 percent. ... we have been committed to innovation and the science behind ...
(Date:1/16/2017)... Research and Markets has announced the addition ... to their offering. ... Global multiple myeloma drugs market to grow at a CAGR ... covers the present scenario and the growth prospects of the global ... the report considers the revenue generated from the sales of branded ...
Breaking Medicine Technology: